Modern Drug Delivery and Adherence
Adherence to daily injections has historically been a challenge in GHD treatment. In 2026, the Italian market has shifted toward Smart Injection Devices and Long-Acting Growth Hormone (LAGH) formulations.
Electronic Auto-injectors: Devices like the Easypod or Aluetta are common in Italy. These devices record the date and time of every injection, allowing doctors to monitor adherence through digital health platforms.
Weekly Formulations: New once-weekly injections are now being utilized, significantly reducing the "needle burden" for children and increasing the likelihood that they will stay on their treatment plan.
Regional Monitoring: Some Italian regions, such as Piedmont and Lombardy, use centralized registries to track drug wastage and ensure that prescriptions match the patient's actual needs.